dm+d

108603001

Articles

Search Articles

Medicine Compliance Aid Stability

SupralipMylan

Mylan
Supralip
Tablets f/c 160mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Protect from moisture.
17 November 2022

Lipantil MicroMylan

Mylan
Lipantil Micro
Capsules 67mg, 200mg, 267mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special precautions for storage
17 November 2022

Lactation Safety Information

No
Bile acid sequestrants (if appropriate)
No published evidence of safety
Serious adverse effects reported in adults
Possible impact on neonatal development
18 September 2020